+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid improves indices of liver injury in nonalcoholic steatohepatitis



Ursodeoxycholic acid improves indices of liver injury in nonalcoholic steatohepatitis



Gastroenterology 106(4 Suppl. ): A926




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144831

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid for nonalcoholic steatohepatitis. European Journal of Gastroenterology and Hepatology 24(11): 1247-1253, 2013

Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis. Official Gazette of the United States Patent & Trademark Office Patents 1251(1), Oct 2, 2001

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Canadian Journal of Gastroenterology 17(12): 713-718, 2003

Ursodeoxycholic Acid For The Treatment Of Nonalcoholic Steatohepatitis: Panacea Or Placebo?. Evidence-Based Gastroenterology 5(4): 122-123, 2004

Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease. Internal Medicine 55(15): 2019-2023, 2017

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39(3): 770-778, 2004

A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis. Hepatology International 4(3): 628-633, 2010

Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis. Clinical Lipidology 8(4): 411-418, 2013

Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Gastrointestinal Endoscopy 76(4): 756-760, 2013

Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. Clinics and Research in Hepatology and Gastroenterology 36(2): 146-155, 2012

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology 4(12): 1537-1543, 2006

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis results of a randomized, placebo controlled trial. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 336, 2003

Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver International 29(8): 1184-1188, 2009

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized, placebo-controlled trial. Gastroenterology 124(4): A708-A709, 2003

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 302(8): G762-G772, 2012